Simon James Grant
Direktor/Vorstandsmitglied bei Inanga AB
Profil
Simon James Grant is currently a Director at ExScale Biospecimen Solutions AB and Inanga AB.
Previously, he was the Chief Executive Officer at Neoventa Medical AB, a Principal at Synectics Medical AB, and the President at SciBase Holding AB for a brief period in 2023.
Aktive Positionen von Simon James Grant
Unternehmen | Position | Beginn |
---|---|---|
Inanga AB
Inanga AB Miscellaneous Commercial ServicesCommercial Services Inanga AB provides technical consulting and artistic creation services. The private company is based in Danderyd, Sweden. | Direktor/Vorstandsmitglied | - |
ExScale Biospecimen Solutions AB
ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Simon James Grant
Unternehmen | Position | Ende |
---|---|---|
SCIBASE HOLDING AB (PUBL) | Vorstandsvorsitzender | 01.10.2023 |
Synectics Medical AB
Synectics Medical AB Information Technology ServicesTechnology Services Part of Medtronic Plc, Synectics Medical AB is a Swedish company that develops computer support systems for the healthcare industry. The company is based in Stockholm, Sweden. The company was founded by Anders Essen-Möller. Synectics Medical was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on March 11, 1996 for $59 million. | Corporate Officer/Principal | - |
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCIBASE HOLDING AB (PUBL) | Health Technology |
Private Unternehmen | 4 |
---|---|
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Health Technology |
Synectics Medical AB
Synectics Medical AB Information Technology ServicesTechnology Services Part of Medtronic Plc, Synectics Medical AB is a Swedish company that develops computer support systems for the healthcare industry. The company is based in Stockholm, Sweden. The company was founded by Anders Essen-Möller. Synectics Medical was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on March 11, 1996 for $59 million. | Technology Services |
Inanga AB
Inanga AB Miscellaneous Commercial ServicesCommercial Services Inanga AB provides technical consulting and artistic creation services. The private company is based in Danderyd, Sweden. | Commercial Services |
ExScale Biospecimen Solutions AB
ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Health Technology |